Defining molecular initiating events in the adverse outcome pathway framework for risk assessment
TEH Allen, JM Goodman, S Gutsell…
Index: Waldhauser, Katri Maria; Toeroek, Michael; Ha, Huy-Riem; Thomet, Urs; Konrad, Daniel; Brecht, Karin; Follath, Ferenc; Kraehenbuehl, Stephan Journal of Pharmacology and Experimental Therapeutics, 2006 , vol. 319, # 3 p. 1413 - 1423
Full Text: HTML
Citation Number: 22
Abstract
... Search text Anywhere Chem. Res. Toxicol. All Publications/Website. Select a Journal or Book ... For example, a beneficial MIE fits well into pharmacological understanding, as does an adverse MIE in overstimulation pharmacology. ...
Related Articles:
[Bioorganic and Medicinal Chemistry Letters, , vol. 18, # 22 p. 5920 - 5922]